BioSpace News Archive

While there are a wide variety products on the market that claim to alleviate the pain of aching backs and joints, many people still suffer with these ailments.

“I wanted to create a better way to wash, scratch or apply lotion to the back and other hard-to-reach areas,” said an inventor, from Chicago, Ill., “so I invented THE DANIEL’S BACK TOOL.”

Shared Imaging’s continued effort to lead the diagnostic imaging industry with powerful partnerships will be further cemented at RSNA 2018

Planning on shopping this Black Friday and Cyber Monday? Health Canada is reminding consumers to make informed buying decisions, and to be aware of the potential risks with online and cross-border shopping.

Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medical need in pain management, ophthalmology, and oncology, today announced the pricing of its initial public offering of 3,750,000 American Depositary Shares (ADSs)

Bausch Health Companies Inc. announced today the results to date of its pending cash tender offer (the “Tender Offer”), to purchase any and all of its outstanding 7.500% Senior Notes due 2021 (the “Notes”), as well as the anticipated early settlement date for the Tender Offer on Nov. 27, 2018 (the “Early Settlement Date”).

Today at Getinge’s Capital Markets Day the President & CEO Mattias Perjos, together with the Getinge Executive Team, will present the strategy and related Business Area plans needed to improve company performance.

Kleresca® has strengthened its research activities by employing an industrial postdoc to investigate the impact of FLE on skin macrophages.

Medivir AB today announces that MIV-828 has been nominated as a candidate drug (CD) for the treatment of acute myeloid leukemia (AML) and other hematological malignancies.

First Orphan Drug Designation for OBI-888, a novel first-in-class Monoclonal Antibody targeting Globo H, a glycolipid antigen found on multiple tumor types.